相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CYP2C19 Polymorphisms and Antiplatelet Effects of Clopidogrel in Acute Ischemic Stroke in China
Dong-mei Jia et al.
STROKE (2013)
An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Ralph L. Sacco et al.
STROKE (2013)
Carotid endarterectomy and carotid artery stenting utilization trends over time
Matthew R. Skerritt et al.
BMC NEUROLOGY (2012)
Stratifying Carotid Diseases for Endovascular Treatments
Gelin Xu et al.
INTERVENTIONAL NEUROLOGY (2012)
Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin
Young-Hoon Jeong et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Pharmacogenomics of clopidogrel: Evidence and perspectives
Tong Yin et al.
THROMBOSIS RESEARCH (2011)
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Miho Kazui et al.
DRUG METABOLISM AND DISPOSITION (2010)
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
Thomas G. Brott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis
Betti Giusti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Current Management of Extracranial Carotid Occlusive Disease
Gina M. S. Howell et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: A possible mechanism for clopidogrel resistance
K. A. Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis
Jean-Louis Mas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients:: a randomised non-inferiority trial
P. A. Ringleb et al.
LANCET (2006)
Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Jean-Sebastien Hulot et al.
BLOOD (2006)
Protected carotid stenting in high-surgical-risk patients: The ARCHeR results
William A. Gray et al.
JOURNAL OF VASCULAR SURGERY (2006)
Protected carotid-artery stenting versus endarterectomy in high-risk patients
JS Yadav et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical significance of the cytochrome P4502C19 genetic polymorphism
Z Desta et al.
CLINICAL PHARMACOKINETICS (2002)
Molecular basis of ethnic differences in drug disposition and response
HG Xie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
分享论文
